Davide Rossi
Davide Rossi
Oncology Institute of Southern Switzerland
Verified email at
Cited by
Cited by
Analysis of the coding genome of diffuse large B-cell lymphoma
L Pasqualucci, V Trifonov, G Fabbri, J Ma, D Rossi, A Chiarenza, ...
Nature genetics 43 (9), 830-837, 2011
Inactivating mutations of acetyltransferase genes in B-cell lymphoma
L Pasqualucci, D Dominguez-Sola, A Chiarenza, G Fabbri, A Grunn, ...
Nature 471 (7337), 189-195, 2011
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation
G Fabbri, S Rasi, D Rossi, V Trifonov, H Khiabanian, J Ma, A Grunn, ...
Journal of Experimental Medicine 208 (7), 1389-1401, 2011
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia
D Rossi, S Rasi, V Spina, A Bruscaggin, S Monti, C Ciardullo, ...
Blood, The Journal of the American Society of Hematology 121 (8), 1403-1412, 2013
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia
D Rossi, S Rasi, G Fabbri, V Spina, M Fangazio, F Forconi, R Marasca, ...
Blood, The Journal of the American Society of Hematology 119 (2), 521-529, 2012
Genetics of follicular lymphoma transformation
L Pasqualucci, H Khiabanian, M Fangazio, M Vasishtha, M Messina, ...
Cell reports 6 (1), 130-140, 2014
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multipleá…
A Palumbo, S Bringhen, D Rossi, M Cavalli, A Larocca, R Ria, M Offidani, ...
Journal of Clinical Oncology 28 (34), 5101-5109, 2010
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
S Bringhen, A Larocca, D Rossi, M Cavalli, M Genuardi, R Ria, S Gentili, ...
Blood, The Journal of the American Society of Hematology 116 (23), 4745-4753, 2010
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness
D Rossi, A Bruscaggin, V Spina, S Rasi, H Khiabanian, M Messina, ...
Blood, The Journal of the American Society of Hematology 118 (26), 6904-6908, 2011
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma
R Crescenzo, F Abate, E Lasorsa, M Gaudiano, N Chiesa, F Di Giacomo, ...
Cancer cell 27 (4), 516-532, 2015
Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia
D Rossi, H Khiabanian, V Spina, C Ciardullo, A Bruscaggin, R FamÓ, ...
Blood, The Journal of the American Society of Hematology 123 (14), 2139-2147, 2014
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development
D Rossi, V Trifonov, M Fangazio, A Bruscaggin, S Rasi, V Spina, S Monti, ...
Journal of Experimental Medicine 209 (9), 1537-1551, 2012
The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness
D Rossi, M Cerri, C Deambrogi, E Sozzi, S Cresta, S Rasi, L De Paoli, ...
Clinical cancer research 15 (3), 995-1004, 2009
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia
D Rossi, M Fangazio, S Rasi, T Vaisitti, S Monti, S Cresta, S Chiaretti, ...
Blood, The Journal of the American Society of Hematology 119 (12), 2854-2862, 2012
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.
A Palumbo, M Cavo, S Bringhen, E Zamagni, A Romano, F Patriarca, ...
Journal of Clinical Oncology 29, 986-993, 2011
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation
D Rossi, V Spina, C Deambrogi, S Rasi, L Laurenti, K Stamatopoulos, ...
Blood, The Journal of the American Society of Hematology 117 (12), 3391-3401, 2011
Hypermethylation of the DNA Repair Gene O6-Methylguanine DNA Methyltransferase and Survival of Patients With Diffuse Large B-Cell Lymphoma
M Esteller, G Gaidano, SN Goodman, V Zagonel, D Capello, B Botto, ...
Journal of the National Cancer Institute 94 (1), 26-32, 2002
Recurrent mutations refine prognosis in chronic lymphocytic leukemia
P Baliakas, A Hadzidimitriou, LA Sutton, D Rossi, E Minga, N Villamor, ...
Leukemia 29 (2), 329-336, 2015
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients
F Gay, A Larocca, P Wijermans, F Cavallo, D Rossi, R Schaafsma, ...
Blood, The Journal of the American Society of Hematology 117 (11), 3025-3031, 2011
Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia
E Tiacci, JH Park, L De Carolis, SS Chung, A Broccoli, S Scott, F Zaja, ...
New England Journal of Medicine 373 (18), 1733-1747, 2015
The system can't perform the operation now. Try again later.
Articles 1–20